ACAD has 36-month beta value of 0.41. Analysts have mixed views on the stock, with 6 analysts rating it as a “buy,” 2 as “overweight,”
Acadia Pharmaceuticals Inc (NASDAQ: ACAD) has seen a rise in its stock price by 1.97 in relation to its previous close of 17.80. However, the
The stock of Acadia Pharmaceuticals Inc (ACAD) has gone up by 3.54% for the week, with a -22.44% drop in the past month and a
The stock of Acadia Pharmaceuticals Inc (ACAD) has seen a -2.47% decrease in the past week, with a -30.96% drop in the past month, and
In the past week, ACAD stock has gone down by -6.41%, with a monthly decline of -25.53% and a quarterly plunge of -34.57%. The volatility
© 2024, Fueled by Smart TechOne
